Clinical Trials Directory

Trials / Unknown

UnknownNCT03540186

Epigenorm Antivir Combined With Acupuncture for the Treatment of Osteoarthritis Patients Who Are Overweight or Obese

A Nutritional Supplement Epigenome Antivir Combined With Acupuncture for the Treatment of Osteoarthritis Who Are Overweight or Obese

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The study evaluates analgesic, antiinflammatory and metabolic effects of a supplement Epigenome-Antivir (extracts of glycyrrhiza roots, hippophae rhamnoides leaves, curcumin, green tea, and vitamin C) combined with acupuncture in patients with knee osteoarthritis (OA) and metabolic syndrome.

Detailed description

Epigenome-Antivir components have long been used in traditional medicine and have been shown to exert anti-inflammatory properties both in vitro and in vivo. It has also been shown that acupuncture can provide a moderate analgesic effect in osteoarthritis. It is anticipated that the combination of Epigenome-Antivir and acupuncture will reduce pain, inflammatory and metabolic markers in patients with OA and metabolic syndrome.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTEpigenorm Antivir1 capsule of Epigenorm Antivir twice daily for 3 months
PROCEDUREAcupunctureAcupuncture involves inserting sterile needles into the skin. The needles do not go into the skin very far. Number of acupuncture sessions: no less than 15 sessions, based on the physician discretion

Timeline

Start date
2018-06-29
Primary completion
2018-11-01
Completion
2018-11-01
First posted
2018-05-30
Last updated
2018-07-02

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT03540186. Inclusion in this directory is not an endorsement.